Polsky Urologic Cancer Institute Research Award
The Polsky Urologic Cancer Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital is committed to driving transformative new insights and successes in urologic cancer research, education and discovery. To achieve this mission, the Institute offers awards to support clinical, laboratory or translational projects with promising potential to advance knowledge and foster new, innovative research in the field of urologic oncology.
The 2019 application cycle has closed. Award applications for next year are due June 1, 2020.
About the Funding Opportunity
The objective of the Polsky Urologic Cancer Institute Research Award is to increase understanding of urologic cancers and enable novel approaches to the prevention, detection and treatment of these cancers. Research supported through this mechanism should directly address questions in basic, clinical or translational urologic cancer research and result in meaningful data that could lead to subsequent extramural funding.
Awards are open to scientists (PhD) and physician-scientists (MD or MD/PhD) with a faculty appointment at an academic institution in the United States. Applicants who do not have a Northwestern University appointment must provide a letter of support from a Northwestern University faculty member, who would serve as a collaborator on the project.
Terms of Award/ Funding
Individual projects are funded for up to $200,000 annually for a 1-3 year award period. The amount awarded will be determined based on the merit and feasibility of the proposed research.
Allowable expenses include:
- Lab supplies and equipment
- Lab personnel
- Clinical research coordination, data management and regulatory support
Progress reports will be required at 6 month intervals after funding begins. Awardees will be followed for progress and outcomes, including publications, abstracts, national presentations, later phase studies, and peer-reviewed funded research.
Projects that successfully demonstrate feasibility may be selected to apply for additional funding to further develop their concepts and maximize translational impact.
All proposals will be reviewed by the Polsky Urologic Cancer Institute Scientific Review Committee. The members of this committee are scientists and physician-scientists with demonstrated excellence in urologic cancer research and clinical trials. Proposals will be evaluated for scientific merit, potential impact on the field of urologic oncology, qualifications of the research team, and alignment with the goals and activities of the Polsky Urologic Cancer Institute.
Applications are due by June 1, 2020, and should be submitted electronically as a single PDF file to email@example.com.
A complete application includes:
- Project summary/ abstract (limit 250 words)
- Research plan (limit 5 pages)
- Specific aims
- Expected results/significance and innovation of the proposed project
- Budget (PHS398 form) and budget justification
- Biosketches for PI and key personnel
Institutional endorsement is not required at time of submission.
Questions regarding this funding opportunity should be directed to Mary Kate Keeter at firstname.lastname@example.org.